| |
|
|
|
|
|
|
|||
|
Blood, 1 October 2008, Vol. 112, No. 7, pp. 2878-2885. Prepublished online as a Blood First Edition Paper on July 30, 2008; DOI 10.1182/blood-2008-03-143222.
NEOPLASIA Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma1 Laboratory of Cellular Physiology and Immunology and 2 Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY; 3 St Vincent's Cancer Center, New York, NY; 4 Section of Hematology, Yale University, New Haven, CT; and 5 Program in Hematologic Malignancies, Yale Cancer Center, New Haven, CT
IL17-producing (Th17) cells are a distinct lineage of T helper cells that regulate immunity and inflammation. The role of antigen-presenting cells in the induction of Th17 cells in humans remains to be fully defined. Here, we show that human dendritic cells (DCs) are efficient inducers of Th17 cells in culture, including antigen-specific Th17 cells. Although most freshly isolated circulating human Th17 cells secrete IL17 alone or with IL2, those induced by DCs are polyfunctional and coexpress IL17 and IFN
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||